Abstract
Bacterial biofilms on medical devices are a primary source of infection, and efforts have been made to develop means of decontaminating colonized devices including hemodialysis catheter “lock” solutions. Because bacterial biofilms are inherently resistant to many antibiotics and widespread use of antibiotics contributes to resistance development, there is a need for new approaches to biofilm eradication. We have developed a class of compounds, termed ceragenins, that mimic the antimicrobial activities of antimicrobial peptides. The ceragenins are active against established biofilms. We tested solutions of a lead ceragenin, CSA-13, with and without EGTA against biofilms comprised of Gram-negative and positive organisms. Similar solutions containing ciprofloxacin were used as comparators. The ceragenin solutions eradicated biofilms at concentrations comparable to those required for eradication by ciprofloxacin. However, against a methicillin- resistant strain of Staphylococcus aureus, CSA-13 proved to be far superior to ciprofloxacin.
Anti-Infective Agents in Medicinal Chemistry
Title: Activities of Ceragenin CSA-13 Against Established Biofilms in an In Vitro Model of Catheter Decolonization
Volume: 8 Issue: 4
Author(s): Jacob Pollard, Jon Wright, Yanshu Feng, Dianliang Geng, Carl Genberg and Paul B. Savage
Affiliation:
Abstract: Bacterial biofilms on medical devices are a primary source of infection, and efforts have been made to develop means of decontaminating colonized devices including hemodialysis catheter “lock” solutions. Because bacterial biofilms are inherently resistant to many antibiotics and widespread use of antibiotics contributes to resistance development, there is a need for new approaches to biofilm eradication. We have developed a class of compounds, termed ceragenins, that mimic the antimicrobial activities of antimicrobial peptides. The ceragenins are active against established biofilms. We tested solutions of a lead ceragenin, CSA-13, with and without EGTA against biofilms comprised of Gram-negative and positive organisms. Similar solutions containing ciprofloxacin were used as comparators. The ceragenin solutions eradicated biofilms at concentrations comparable to those required for eradication by ciprofloxacin. However, against a methicillin- resistant strain of Staphylococcus aureus, CSA-13 proved to be far superior to ciprofloxacin.
Export Options
About this article
Cite this article as:
Pollard Jacob, Wright Jon, Feng Yanshu, Geng Dianliang, Genberg Carl and Savage B. Paul, Activities of Ceragenin CSA-13 Against Established Biofilms in an In Vitro Model of Catheter Decolonization, Anti-Infective Agents in Medicinal Chemistry 2009; 8 (4) . https://dx.doi.org/10.2174/187152109789760225
DOI https://dx.doi.org/10.2174/187152109789760225 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Applications of Microemulsion Based Drug Delivery System
Current Drug Delivery Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Applied Proteomics in Companion Animal Medicine
Current Proteomics Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets Novel Chemically Modified Bacterial Cellulose Nanocomposite as Potential Biomaterial for Stem Cell Therapy Applications
Current Stem Cell Research & Therapy The Metabolic Fate of Apple Polyphenols in Humans
Current Nutrition & Food Science Editorial [Hot Topic: Protective or Damaging Immunity in Infection (Guest Editors: Jose Gutierrez and Antonio Sorlozano)]
Current Immunology Reviews (Discontinued) Editorial (Thematic Issue: Sensory Science of Oral Health for Creating New Preventive Medicines)
Current Pharmaceutical Design A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Current Drug Metabolism Editorial (Thematic Issue: Special Issue in Memory of Prof. Dr. Luis Eduardo Diaz: Current Topics in Pharmaceutical Biotechnology)
Current Pharmaceutical Biotechnology Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Preparation and in vitro Evaluation of α and β -Amyrins Loaded Nanoemulsions
Current Pharmaceutical Biotechnology Current and Future Challenges in Primary Sjogren’s Syndrome
Current Pharmaceutical Biotechnology Adipose-Derived Stem Cells and Platelet-Rich Plasma: The Keys to Functional Periodontal Tissue Engineering
Current Stem Cell Research & Therapy The Repurposing of Old Drugs or Unsuccessful Lead Compounds by in Silico Approaches: New Advances and Perspectives
Current Topics in Medicinal Chemistry Perspectives in Medicinal Chemistry: Metalloprotein Inhibitors: What Have We Made and What is the Next Step?
Current Topics in Medicinal Chemistry Tailoring an Antibacterial Peptide of Human Lysosomal Cathepsin G to Enhance its Broad-Spectrum Action Against Antibiotic-Resistant Bacterial Pathogens
Current Pharmaceutical Design Mucoadhesive Buccal Systems as a Novel Strategy for Anti-Inflammatory Drugs Administration
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Use of Propolis in Micro/Nanostructured Pharmaceutical Formulations
Recent Patents on Drug Delivery & Formulation Role of Phytochemicals in the Prevention of Menopausal Bone Loss: Evidence from In Vitro and In Vivo, Human Interventional and Pharmacokinetic Studies
Current Medicinal Chemistry